
Study Links TikTok Skincare Routines to Lifelong Skin Allergies and Other Risks
A search for the hashtag 'skincare' on TikTok turns up more than 35 million videos, but most follow the same formula. 'Get ready with me,' a beauty influencer coos before walking viewers through their routine, which often involves several steps and a slew of products. These videos are wildly popular, but new research suggests they may do more harm than good.
In the first study of the risks and benefits of social media skincare routines—published today in the journal Pediatrics—Northwestern University researchers analyzed the regimens of TikTok creators aged seven to 18. The findings revealed that these girls use an average of six different products on their faces, and some use more than a dozen. The typical routine costs roughly $168 per month and includes 11 different active ingredients, which are chemicals designed to address a specific skin concern such as acne or aging.
The creators of these videos are chasing flawless skin, and they want to help you find it too. But the reality is that layering this many active ingredients at once increases the risk of developing skin irritation, Sun sensitivity, and a skin allergy known as contact dermatitis, according to the researchers. Previous studies have shown that developing this allergy can limit the kinds of soaps, shampoos, and cosmetics you can use for the rest of your life.
'That high risk of irritation came from both using multiple active ingredients at the same time, such as hydroxy acids, as well as applying the same active ingredient unknowingly over and over again when that active ingredient was found in three, four, five different products,' said lead author Molly Hales, a postdoctoral research fellow and dermatologist at Northwestern University Feinberg School of Medicine, according to a university statement.
For this study, Hales and a colleague each created a new TikTok account and reported themselves to be 13 years old. They gathered a sample of 100 unique skincare videos, then documented the demographics of the creators; the number and types of products used; and the total cost of each regimen. All but one of the 82 creators were girls with clear, light, blemish-free skin, according to the study. The researchers then created a list of each product's active and inactive ingredients and identified which were most likely to cause contact dermatitis.
The 100 videos featured 260 distinct products. Among the 25 top-viewed videos, 76% contained at least one potential contact allergen—typically fragrance. But the most common ingredients were chemical exfoliants called alpha-hydroxy acids (AHAs). The top videos contained three AHAs per regimen on average, with some featuring up to seven of these exfoliants. The most popular active ingredient, citric acid, was found in 29% of all products.
AHAs can cause skin irritation and increase Sun sensitivity, according to the Food and Drug Administration. Because of this, it's important to use these ingredients in moderation and follow them with SPF to prevent sunburn and reduce the risk of developing skin cancer. Despite this, only 26% of videos about daytime skincare routines included sunscreen.
'The overall low rate of sunscreen use in the videos represents a significant missed opportunity, particularly for the youngest creators and users who do not yet need acne treatments, antiaging ingredients, or even topical emollients but would benefit from diligent sun protection,' the authors state. In one video, a 10-year-old with red hair and fair, freckled skin—which are markers of melanoma risk—applied eight different products, none of which contained SPF.
Gizmodo reached out to TikTok for comment, but the company did not respond by the time of publication. A TikTok spokesperson told The Guardian, 'this type of content is common across all media, and the authors admit they did not assess its impact on teen wellbeing. However, they did find actual benefits to teen self-expression, parent-teen bonding, and building a supportive community on TikTok.'
Still, the researchers concluded that these videos 'offer little to no benefit for the pediatric populations they are targeting.' The regimens are overly complicated, time consuming, expensive, and increase children's exposure to irritation, allergy, and sun damage, they say.
What's more, the proliferation of skincare content has increased the stigma around acne, eczema, aging, and other skin conditions, Tess McPherson of the British Association of Dermatologists—who was not involved in the study—told The Guardian.
'Younger and younger children are seeking skincare products when they don't need them, they're not helpful,' she said. 'This is a very concerning statement on society and how we view how skin should look.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Health Line
23 minutes ago
- Health Line
Is There an Azstarys Shortage?
Azstarys is a prescription drug used to treat ADHD. Some ADHD medications have recently been in short supply. Learn whether Azstarys is affected and how to check its availability. Azstarys is not currently listed in the Food and Drug Administration (FDA) drug shortages database. Here's what to know about why some ADHD medications may be hard to find and how to check for drug shortages. Is there a shortage of other ADHD drugs? In recent years, several ADHD medications have been in short supply. A few examples include Adderall, Concerta, Ritalin, and Vyvanse. It's not yet clear when these shortages will fully resolve. These shortages have affected both brand-name and generic versions of the drugs. As a result, some people have worked with their doctor to switch to a different medication or adjust their ADHD treatment plan. To check the current status of Aztarys and other ADHD medications, visit the FDA drug shortages website. How do ADHD drug shortages affect people? Shortages of ADHD medications can make it harder for people to stick with their treatment plan. This can cause ADHD symptoms to return or become more difficult to manage. A lack of consistent access to ADHD medication may also increase stress and affect mental health. Other possible effects of disrupted access to ADHD medication include: difficulty focusing or completing daily tasks increased impulsivity or emotional outbursts difficulty falling or staying asleep withdrawing from social, family, or work activities If you're having trouble filling a prescription for an ADHD medication, talk with your doctor or pharmacist. They may recommend alternatives or adjust your treatment plan based on what's available. What causes a drug shortage? Several factors can lead to a medication being in short supply. Common causes of ADHD drug shortages include: Increased demand: More people receiving diagnoses of ADHD have led to greater demand for medications. This can strain manufacturers and reduce availability at pharmacies. Regulatory limits: Stimulant medications used to treat ADHD, including Azstarys, are controlled substances. The Drug Enforcement Administration (DEA) sets yearly production limits for these medications. If demand rises suddenly, these limits may contribute to shortages. Supply chain issues: Shortages of raw materials, packaging supplies, or labor can delay the manufacturing and availability of ADHD drugs. When multiple ADHD medications are in short supply at the same time, it can be especially hard for pharmacies to keep any option in stock. Even when generic forms are available, they may be affected by the same issues as brand-name drugs. As a result, generics may be just as difficult to find during a shortage. How can I check whether Azstarys is available near me? Azstarys is not currently listed by the FDA as being in shortage. However, some people may still experience delays when trying to fill their prescription. Availability can vary depending on your pharmacy, location, and insurance plan. If you're having trouble finding Azstarys, start by talking with a pharmacist. If possible, visit the pharmacy in person. Some pharmacies may not share inventory details for ADHD medications over the phone. You can also check pharmacy websites or apps, which sometimes offer tools to look up availability online. Keep in mind that availability may change as new shipments arrive. You can also check with your insurance provider. If Azstarys isn't available through your plan's preferred pharmacy, your insurer may be able to help you locate another pharmacy. In some cases, you may want to reach out to the drug manufacturer for information about availability in your area. To learn more about contacting the manufacturer, visit the Azstarys website.


Bloomberg
26 minutes ago
- Bloomberg
CRISPR Is Direct Result of Federal Funding: Doudna
President Donald Trump on Monday threatened to divert billions in grant dollars away from Harvard University and give those funds to trade schools across the US, escalating his clash with the elite institution. Jennifer Doudna, a winner of the Nobel Prize in chemistry for development of CRISPR gene editing said that federal funding is essential for search like hers to start. (Source: Bloomberg)


Fox News
36 minutes ago
- Fox News
RFK Jr scraps vaccine committee members in effort to restore 'public trust'
The Department of Health and Human Services dismissed all the members of the Advisory Committee on Immunization Practices (ACIP) on Monday. The committee's job was to decide and "make recommendations" related to the necessity and use of vaccines, according to an HHS news release. All the current members of the committee were brought in under the Biden administration, and 13 of them were put on the committee last year. HHS said it would take until 2028 for most of the members to be replaced if they served their full term. Public debate about vaccines, especially whether government or workplaces should mandate them, escalated during the COVID-19 pandemic. Much of the criticism and skepticism fell on the Centers for Disease Control and Prevention, which ACIP advises. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Secretary Robert F. Kennedy said in a statement on Monday. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies." The HHS release noted that the next meeting for the committee will be June 25-27 in Atlanta, and the committee will have new people that are "currently under consideration." "A clean sweep is necessary to reestablish public confidence in vaccine science," Kennedy continued. "ACIP's new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas. The entire world once looked to American health regulators for guidance, inspiration, scientific impartiality, and unimpeachable integrity. Public trust has eroded. Only through radical transparency and gold standard science, will we earn it back." HHS cited an executive order from President Donald Trump saying that changes were needed in how the federal government plays a role in science and health. "Unfortunately, the Federal Government has contributed to this loss of trust. In several notable cases, executive departments and agencies (agencies) have used or promoted scientific information in a highly misleading manner," the order stated. "For example, under the prior Administration, the Centers for Disease Control and Prevention issued COVID-19 guidance on reopening schools that incorporated edits by the American Federation of Teachers and was understood to discourage in-person learning," the order, signed on May 23, continued. "This guidance's restrictive and burdensome reopening conditions led many schools to remain at least partially closed, resulting in substantial negative effects on educational outcomes — even though the best available scientific evidence showed that children were unlikely to transmit or suffer serious illness or death from the virus, and that opening schools with reasonable mitigation measures would have only minor effects on transmission," it added. Kennedy was confirmed by the Senate to lead the department in February after Trump nominated him.